Home

Introducing med•wave®
The Gentle
Digital
Middle Ear Analyzer
Quick.
Non-invasive.
Objective.
Introducing med•wave®
The Gentle
Digital
Middle Ear Analyzer

Quick.
Non-invasive.
Objective.

Why Specialists And Pediatricians choose med•wave®

QUICK.

The device is easy to handle,quick, and simple to use: the test is completed in less than 2-3 seconds per ear.

NON-INVASIVE.

Patients remain comfortable: the test is non-invasive and painless even when the ear is sensitive or inflamed.

OBJECTIVE.

Testing is accurate, repeatable and objective in both analysis and suggestions for diagnosis.

SAFE

Particularly indicated in pediatrics, med·wave® can be utilized on patients starting from 2 years.

QUICK.
The device is easy to handle,quick, and simple to use: the test is completed in less than 2-3 seconds per ear.
NON-INVASIVE.
Patients remain comfortable: the test is non-invasive and painless even when the ear is sensitive or inflamed.
OBJECTIVE.
Testing is accurate, repeatable and objective in both analysis and suggestions for diagnosis.
SAFE.
Particularly indicated in pediatrics, med·wave® can be utilized on patients starting from 2 years.

The first instrument with
Pressure Less Acoustic
Immittance methodology

PLAI® impulse. The only device that uses multifrequency chirp stimulation from 100 to 1500 Hz.

Patented Technology
PLAI® (Pressure Less Acoustic Immittance) is patented Neuranix methodology developed with the Ferrara CNR National Research Center.

Simplicity.
PLAI® methodology lets device complexity be reduced significantly. No pressure pump system is required to change the pressure in the external ear canal, which also reduces machine downtime risks while improving patient safety.

No pressure.
Pressure-less testing be performed even on damaged eardrums.

Non-invasive is synonymous with serenity for patients, family members, and operators. Serenity is a top priority for us.

Test execution speed amounts to just seconds. No need to check the pressure seal or probe positioning problems that reportedly arise in 21% of cases. *

PLAI® impulse.

The only device that uses multifrequency chirp stimulation from 100 to 1500 Hz.

Patented Technology PLAI®.
(Pressure Less Acoustic Immittance) is patented Neuranix methodology developed with the Ferrara CNR National Research Center.
Simplicity.
PLAI® methodology lets device complexity be reduced significantly. No pressure pump system is required to change the pressure in the external ear canal, which also reduces machine downtime risks while improving patient safety.
No pressure.
Pressure-less testing be performed even on damaged eardrums.
Test execution speed
amounts to just seconds. No need to check the pressure seal or probe positioning problems that reportedly arise in 21% of cases. *
Non-invasive
is synonymous with serenity for patients, family members, and operators. Serenity is a top priority for us.
*White paper: “Pros and cons of traditional tympanometry: the Customer’s Voice”- Dr. Flavia Sorrentino – Dr. Marco Greggio, September, 2022

Using such an innovative device has never been so easy

Middle ear analysis today is performed with tools that present several disadvantages. The probe must be inserted in the external ear canal. Tip size and shape must be selected and tested exactly before positive and negative pressure can be applied. This type of testing can last minutes. Alternatively, an otoscopy—a visual, not a functional ear exam—is performed. Although it may be fast, results are subjective and cannot be compared with other data.

Med·wave® introduces a new, non-invasive and objective middle ear analysis method, and the innovative test technology takes only seconds.

Traditional examination can be difficult for infants, young children, and pathological patients who cannot withstand the pressure applied to the ear because it causes them pain, especially when repeated testing is required.

Based on simple data acquisition processes, med·wave® adopts an automatic method that aligns the probe in the external ear canal, minimizes operator intervention, and shortens the learning curve.

When best indicated for use by doctors and patients:

1. Audiological assessment

med·wave® can be used during routine examinations to assess eardrum and middle ear status.

3. Inflammation

med·wave® permits non-invasive eardrum and middle ear status assessment. Subsequently it indicates worsened or improved conditions following pharmacological treatment.

2. Pediatric assessment

med·wave® collects data under normal pediatric patient conditions. In subsequent case of suspected pathology, it lets pediatricians compare new exams with previous tests saved in the database.

3. Inflammation
med·wave® permits non-invasive eardrum and middle ear status assessment. Subsequently it indicates worsened or improved conditions following pharmacological treatment.
4. Suspected perforation
Thanks to the absence of painful changes in pressure, med·wave® testing poses no risk when perforation is suspected after otoscopic evaluation, accurately indicating whether perforation is present or not.

The best choice for:

Pediatrics

Ent Doctors

Audiologists

Find out more:
Capitale sociale 18.813,99 € non I.V. Registro imprese di Napoli NA-971341